Man Sues Manufacturers of Testim After Suffering Heart Attack

As human beings, we have the potential to be influenced by ad campaigns. Some drug companies, in particular, spend huge chunks of change in order to get their message across and sell their product. However, it may not always be ethical for them to do so.

A problem has arisen recently which some say is due to the aggressive marketing of drugs used to treat a condition that the companies have highly exaggerated. Drug companies are accused of leading men to think that testosterone therapy could restore their youthful vitality, even though testosterone levels naturally decrease in men as they get older.

There have been many lawsuits filed against the makers of testosterone therapy drugs; the latest one was filed recently in the Common Pleas Court in Philadelphia by a 67-year-old man and his wife. They are suing for an unspecified amount for negligent misrepresentation, strict liability and negligence, among other things. In addition, the wife is suing for loss of marital consortium. They claim that the manufacturers knew that Testim was a dangerous drug, but did not do enough to warn users about the potential risks.

The couple say that the man began using Testim, a testosterone gel that is placed on the upper arms, in May 2012. Although he has never had heart problems, he had a heart attack about a year later. He believes the heart attack was a direct result of using Testim.

If you have experienced heart problems or stroke while on a testosterone replacement therapy, you may wish to speak with an attorney about your case.

Source: The Pennsylvania Record, “Ross Feller Casey files second testosterone gel injury complaint in Phila.,” Jon Campisi, Mar. 19, 2014

Eisenberg, Rothweiler Logo

It takes a specific mindset, specialized skills and substantial resources. The types of cases we handle are not the average personal injury. They involve severe, permanent injuries to people that radically affect their lives forever, or in some instances, even cause their death.